FLT3 Gene Mutation Negative
Clinical trial pipeline · Data from ClinicalTrials.gov
See which FLT3 Gene Mutation Negative trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which FLT3 Gene Mutation Negative trials you may qualify forThis study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase…
This phase Ib trial tests the safety, side effects, and best dose of SNDX-5613 when given in combination with the standard chemotherapy treatment (daunorubicin…
Randomized phase II trial to compare the efficacy and safety of standard chemotherapy plus quizartinib versus standard chemotherapy plus placebo in adult patien…
This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients wit…